Moderna, Inc.Moderna, Inc.
MRNA
Nasdaq
Annual financials
| Period | Revenue | Operating income | Net income | EPS |
|---|---|---|---|---|
| 2025-12-31 | 1,944,000,000 | -3,074,000,000 | -2,822,000,000 | -7.26 |
| 2024-12-31 | 3,236,000,000 | -3,945,000,000 | -3,561,000,000 | -9.28 |
| 2023-12-31 | 6,848,000,000 | -4,239,000,000 | -4,714,000,000 | -12.33 |
| 2022-12-31 | 19,263,000,000 | 9,420,000,000 | 8,362,000,000 | 20.12 |
| 2021-12-31 | 18,471,000,000 | 13,296,000,000 | 12,202,000,000 | 28.29 |
Insider filings (Forms 3/4/5)
| Date | Owner | Title | Shares |
|---|---|---|---|
| 2026-09-04 | Mock James M | Chief Financial Officer | 11,797 |
| 2026-09-04 | Mock James M | Chief Financial Officer | 5,704 |
| 2026-09-04 | Mock James M | Chief Financial Officer | 11,797 |
| 2026-09-04 | Klinger Shannon Thyme | Chief Legal Officer | 11,797 |
| 2026-09-04 | Klinger Shannon Thyme | Chief Legal Officer | 5,704 |
| 2026-09-04 | Klinger Shannon Thyme | Chief Legal Officer | 11,797 |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | 3,471 |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | 3,471 |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | 2,166 |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | 1,048 |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | 3,471 |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | 2,166 |
8-K events
| Filed | Items |
|---|---|
| 2026-09-01 | Entry into a material agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Other events · Financial statements and exhibits |
| 2026-07-31 | Results of operations · Financial statements and exhibits |
| 2026-07-08 | Officer or director change · Regulation FD disclosure · Financial statements and exhibits |
| 2026-05-11 | Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits |
| 2026-05-01 | Results of operations · Financial statements and exhibits |
| 2026-03-05 | Entry into a material agreement |
| 2026-02-13 | Results of operations · Financial statements and exhibits |
| 2026-02-11 | Regulation FD disclosure · Other events · Financial statements and exhibits |
Congressional trades (PTR)
| Member | Filed |
|---|---|
| Hon. Maria Elvira Salazar | 2026-09-09 |
—
이 종목 한 문단This stock in a paragraph
같은 업종과 비교Compared with its industry
수익성·성장·가격 배수·안정성을 합쳐 본 현재의 자리입니다. 앞으로의 움직임이나 투자 판단을 뜻하지 않습니다.Its current position across profitability, growth, valuation and stability — not a verdict or a view of what comes next.
계산법과 출처Method and sources
모르는 말이 있나요? 공식 종가 · 전고점 대비 · 실현 변동성 New to these? Official close · Drawdown · Realized volatility
가격 차트Price chart
기술지표Technical indicators
고급 가격 구간 보기Advanced price levels
이 사건들을 어떻게 찾았나How these events are found
계산법과 출처Method and sources
Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size
SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.
연간 재무제표와 비율Annual financials and ratios
실적 규모Business scale
비율과 추이Ratios and trends
계산법과 출처Method and sources
PER·PBR, 과거와 비교P/E and P/B versus their history
계산법과 출처Method and sources
잠정실적 — 회사 발표Preliminary results — company announcement
계산법과 출처Method and sources
분기로 보는 재무Quarter by quarter
3개월 값 · 예측 아님Three-month figures · not a forecast
지표 — 최근 분기, 전년 같은 분기 대비Indicators — latest quarter vs the same quarter a year ago
계산법과 출처Method and sources
재무제표 상세Financial statement details
계산법과 출처Method and sources
기업 정보Company information
회사 개요부터 배당·주주·직원·이사회까지Profile, dividends, shareholders, employees and board
회사 개요Company profile
배당Dividends
최대주주와 특수관계인Largest shareholder and related parties
주식 수·자기주식·소액주주Shares, treasury stock, minority holders
직원Employees
임원 · 이사회Board and executives
계산법과 출처Method and sources
같은 업종Same industry
계산법과 출처Method and sources
내부자 거래Insider trades
계산법과 출처Method and sources
옵션 시장 한눈에Options at a glance
공식 마감값 · 실시간 아님 · 예측 아님Official close · not live · not a forecast
세부 지표와 시장 쏠림Detailed indicators and positioning
태그는 지금의 쏠림을 요약하며 주가의 상승·하락을 예측하지 않습니다.Tags summarize current positioning; they do not predict the stock's direction.
계산법과 출처Method and sources
공시 이벤트Filing events
계산법과 출처Method and sources
관련 뉴스Related news
이 종목 이름이 제목에 들어간 기사Articles whose headline names this stock
계산법과 출처Method and sources
종목 검색 관심도Search interest
×1보다 크면 평소보다 많이 찾아봤다는 뜻입니다. 요일마다 검색량이 크게 달라서 같은 요일끼리만 견줍니다.Above ×1 means more searches than usual. Weekday volume swings a lot, so we compare like weekday with like.